Monday, November 23, 2015 |
||||||
YOUR BEST SOURCE FOR THE UNBIASED MARKET COMMENTARY YOU WON’T GET FROM WALL STREET | ||||||
You can also access this issue on our website. | ||||||
Uncle Sam Vs. Pfizer: The $160 Billion Battle Over Taxes, Consolidation
|
||||||
By Mike Larson | ||||||
The U.S. pharmaceutical giant said it would acquire Allergan PLC (AGN)
in a transaction worth about $160 billion in stock, cash, and debt. The
deal would combine drugs and vaccines that treat everything from cancer
to arthritis to pneumonia, and the wrinkle-fighting treatment Botox and
erectile dysfunction product Viagra, under one roof — creating the
world’s largest Big Pharma firm.
|
||||||
Mike Larson graduated
from Boston University with a B.S. degree in Journalism and a B.A.
degree in English in 1998, and went to work for Bankrate.com.
There, he learned the mortgage and interest rates markets inside and
out. Mike then joined Weiss Research in 2001. He is the editor of Safe Money Report. He is often quoted by the Washington Post, Reuters, Dow Jones Newswires, Orlando Sentinel, Palm Beach Post and Sun-Sentinel, and he has appeared on CNN, Bloomberg Television and CNBC.
|
||||||
The investment strategy and opinions expressed in this article are those of the author’s and do not necessarily reflect those of any other editor at Weiss Research or the company as a whole. |
Tuesday, November 24, 2015
Uncle Sam Vs. Pfizer: The $160 Billion Battle Over Taxes, Consolidation
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment